StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck operating Lease Undiscounted Cash Flows — Year 3 ($M) ($M)

Form 10-K Note 10 Leases

Latest, FY2025
204
Period ended Dec 31, 2025
Change on a year earlier
-13.2%
235 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOperating Lease Undiscounted Cash Flows — Year 3 ($M) ($M)Year on yearSource
FY2025Dec 31, 2025204-13.2%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 2024235+5.9%Form 10-K (filed 2025-02-25) ↗
FY2023Dec 31, 2023222-0.9%Form 10-K (filed 2024-02-26) ↗
FY2022Dec 31, 2022224-7.4%Form 10-K (filed 2023-02-24) ↗
FY2021Dec 31, 2021242-4.0%Form 10-K (filed 2022-02-25) ↗
FY2020Dec 31, 2020252+50.0%Form 10-K (filed 2021-02-25) ↗
FY2019Dec 31, 2019168–Form 10-K (filed 2020-02-26) ↗

Cite this data

StockData. (2026). Merck Operating Lease Undiscounted Cash Flows — Year 3 ($M) ($M), annual FY2019–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/lease_due_y3

See every metric in the Merck KPI table. Data updated Oct 26, 2026.